Viewing Study NCT01825603


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2026-02-20 @ 6:34 PM
Study NCT ID: NCT01825603
Status: COMPLETED
Last Update Posted: 2023-12-28
First Post: 2013-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
Sponsor: University of Nebraska
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ampulla of Vater Adenocarcinoma View
None Gallbladder Adenocarcinoma View
None Metastatic Pancreatic Adenocarcinoma View
None Pancreatic Adenocarcinoma View
None Stage III Ampulla of Vater Cancer View
None Stage III Intrahepatic Cholangiocarcinoma View
None Stage III Pancreatic Cancer View
None Stage IIIA Gallbladder Cancer View
None Stage IIIA Hilar Cholangiocarcinoma View
None Stage IIIB Gallbladder Cancer View
None Stage IIIB Hilar Cholangiocarcinoma View
None Stage IV Ampulla of Vater Cancer View
None Stage IVA Gallbladder Cancer View
None Stage IVA Hilar Cholangiocarcinoma View
None Stage IVA Intrahepatic Cholangiocarcinoma View
None Stage IVA Pancreatic Cancer View
None Stage IVB Gallbladder Cancer View
None Stage IVB Hilar Cholangiocarcinoma View
None Stage IVB Intrahepatic Cholangiocarcinoma View
None Stage IVB Pancreatic Cancer View
Keywords: